BBH / Biotech Rebound Could Finally Be Afoot

The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healt more_horizontal

VanEck Biotech ETF has outperformed alternative industry ETFs in recent years through its concentration in large-cap leaders. Biotech companies are be more_horizontal

Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC. more_horizontal

In what feels like an eternity in biotechnology terms, broader baskets of the industry's stocks haven't outperformed the S&P 500 Health Care Index ann more_horizontal

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively man more_horizontal

The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory more_horizontal

Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcar more_horizontal

Historically, biotechnology stocks trade at premiums relative to the healthcare and the broader market. That's simply the price of admission investors more_horizontal